FE ANN BRAXTON: Open Payments
NPI 1386373306 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$757 in 36 payments from 10 companies in 2025. Trend: 2023 $193 · 2024 $335 · 2025 $757
Food & beverage: $757
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $221 |
| AstraZeneca Pharmaceuticals LP | 6 | $170 |
| Lilly USA, LLC | 6 | $107 |
| Echosens North America, Inc. | 3 | $87 |
| Axsome Therapeutics, Inc. | 2 | $63 |
| Currax Pharmaceuticals LLC | 2 | $33 |
| Astellas Pharma US Inc | 2 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Phadia US Inc. | 1 | $15 |
| Antares Pharma, Inc. | 1 | $15 |
Products named: AIRSUPRA, Wegovy, MOUNJARO, Fibroscan, Symbravo, Ozempic, JARDIANCE, CONTRAVE.
Industry payments across TX — which companies pay providers there.
